Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KDA GroupKDAGF 3-Year ROIIC % is 18.96 as of Jul. 2025, which is at its 10-year median of 18.96. The stock has 3 warning signs investors should review. Among 617 Healthcare Providers & Services companies, KDA Group ranks better than 72.12% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
KDA Group's 3-Year ROIIC % for the quarter that ended in Jul. 2025 was 18.96%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for KDA Group's 3-Year ROIIC % or its related term are showing as below:
KDAGF's 3-Year ROIIC % is ranked better than 72.12% of 617
companies
in the Healthcare Providers & Services industry
Industry Median: 3.46
vs KDAGF: 18.96
KDA Group (OTCPK:KDAGF) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
KDA Group 3-Year ROIIC % Related Terms
KDA Group 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for KDA Group's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KDAGF vs VEEV, BTSG, TEM: 3-Year ROIIC % Comparison
For the Health Information Services subindustry, KDA Group's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KDA Group 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, KDA Group's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where KDA Group's 3-Year ROIIC % falls into.
KDA Group's 3-Year ROIIC % for the quarter that ended in Jul. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -6.533 (Jul. 2025) - -2.7428166 (Jul. 2022) )
/
( 7.602 (Jul. 2025) - 30.046 (Jul. 2022) )
=
-3.7901834
/
-22.444
=
16.89%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
KDA Group (KDAGF) has a 3-Year ROIIC % of 18.96 as of Jul. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on KDA Group and its competitors. This is near median its historical median of 18.96. According to the industry distribution chart, KDA Group ranks #172 out of 617 companies in the Healthcare Providers & Services industry, placing it in the top 27.9%.
Is KDA Group's 3-Year ROIIC % too high?
KDA Group's current 3-Year ROIIC % of 18.96 is near median its 10-year median of 18.96. The Healthcare Providers & Services industry median 3-Year ROIIC % is 3.46. KDA Group's value of 18.96 is 448% above this industry median. Based on the distribution chart, KDA Group ranks #172 out of 617 companies in the Healthcare Providers & Services industry, which is above the industry midpoint.
How does KDA Group's 3-Year ROIIC % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, KDA Group ranks #172 out of 617 companies for 3-Year ROIIC %. This puts KDA Group in the upper half of its industry. The industry median 3-Year ROIIC % is 3.46. KDA Group's value of 18.96 is 448% above this benchmark. While the company's 10-year median is 18.96 vs. the industry median of 3.46, KDA Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.46, based on 617 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KDA Group's current 3-Year ROIIC % of 18.96 is 448% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on KDA Group and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KDA Group's current 3-Year ROIIC % is 18.96, which is near median its own 10-year median of 18.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KDA Group stock overvalued right now?
KDA Group (KDAGF) has a current 3-Year ROIIC % of 18.96. The current 3-Year ROIIC % is 18.96, which is near median its 10-year median of 18.96 and 448% above the Healthcare Providers & Services industry median of 3.46. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For KDA Group (KDAGF), the current 3-Year ROIIC % is 18.96 as of Jul. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
KDA Group Inc provides technological and operational efficiency solutions for general and specialized health sectors through its technology platform, which includes electronic prescription platforms for Canada and the United States and Adherize and Medherize functionalities for pharmaceutical adherence and oncology-focused therapeutic monitoring. The company operates through two segments: Pharmaceutical Technology and Corporate.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KDAGF has been successfully added to your 
